Cancer drug sorafenib may help save Insulin-Making cells in New-Onset type 1 diabetes
NCT ID NCT06227221
First seen Feb 21, 2026 · Last updated May 01, 2026 · Updated 9 times
Summary
This study tests whether sorafenib, a drug currently used for cancer, can help people with newly diagnosed type 1 diabetes keep making some of their own insulin. Ten adults aged 18-60 will receive either sorafenib or a placebo for a short time. The goal is to see if the drug can slow the loss of insulin-producing cells and improve blood sugar control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.